132 related articles for article (PubMed ID: 29526121)
1. Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs.
Bakker DS; Garritsen FM; Leavis HL; van der Schaft J; Bruijnzeel-Koomen CAFM; van den Broek MPH; de Bruin-Weller MS
J Dermatolog Treat; 2018 Nov; 29(7):682-687. PubMed ID: 29526121
[TBL] [Abstract][Full Text] [Related]
2. Is there an increased risk of cervical neoplasia in atopic dermatitis patients treated with oral immunosuppressive drugs?
Garritsen FM; Verheijen RHM; Gerestein CG; van Zuilen AD; Oosterhaven JAF; van Dijk M; Bruijnzeel-Koomen CAF; Schuttelaar ML; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):271-275. PubMed ID: 28925576
[TBL] [Abstract][Full Text] [Related]
3. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497
[TBL] [Abstract][Full Text] [Related]
4. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
5. Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Garritsen FM; van den Heuvel JM; Bruijnzeel-Koomen CAFM; Maitland-van der Zee AH; van den Broek MPH; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1336-1342. PubMed ID: 29485224
[TBL] [Abstract][Full Text] [Related]
6. Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Garritsen FM; van der Schaft J; van den Reek JM; Politiek K; van Os-Medendorp H; van Dijk M; Hijnen DJ; de Graaf M; Bruijnzeel-Koomen CA; de Jong EM; Schuttelaar MA; Bruin-Weller MS
Acta Derm Venereol; 2017 Jun; 97(6):724-730. PubMed ID: 28218345
[TBL] [Abstract][Full Text] [Related]
7. Severe atopic dermatitis treated with everolimus.
Van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA
J Dermatolog Treat; 2009; 20(6):365-7. PubMed ID: 19954394
[TBL] [Abstract][Full Text] [Related]
8. PD-1 blockade for disseminated Kaposi sarcoma in a patient with atopic dermatitis and chronic CD8 lymphopenia.
Gambichler T; Susok L
Immunotherapy; 2020 May; 12(7):451-457. PubMed ID: 32316815
[TBL] [Abstract][Full Text] [Related]
9. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis.
Vandercam B; Lachapelle JM; Janssens P; Tennstedt D; Lambert M
Dermatology; 1997; 194(2):180-2. PubMed ID: 9094472
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.
Baharnoori M; Gonzalez CT; Chua A; Diaz-Cruz C; Healy BC; Stankiewicz J; Weiner HL; Chitnis T
Mult Scler Relat Disord; 2018 Feb; 20():51-57. PubMed ID: 29304497
[TBL] [Abstract][Full Text] [Related]
12. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
13. Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.
Sondermann W; Rompoti N; Leister L; Huptas L; Klode J; Dissemond J; Körber A
Dermatology; 2017; 233(4):295-302. PubMed ID: 28954274
[TBL] [Abstract][Full Text] [Related]
14. Towards personalized treatment in atopic dermatitis.
van der Schaft J; Thijs JL; Garritsen FM; Balak D; de Bruin-Weller MS
Expert Opin Biol Ther; 2019 May; 19(5):469-476. PubMed ID: 30768375
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases.
Baulier G; Issa N; Gabriel F; Accoceberry I; Camou F; Duffau P
Clin Exp Rheumatol; 2018; 36(3):490-493. PubMed ID: 29533748
[TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.
Vögelin M; Biedermann L; Frei P; Vavricka SR; Scharl S; Zeitz J; Sulz MC; Fried M; Rogler G; Scharl M
PLoS One; 2016; 11(5):e0155218. PubMed ID: 27214202
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis.
Schneeweiss MC; Perez-Chada L; Merola JF
J Am Acad Dermatol; 2021 Aug; 85(2):321-329. PubMed ID: 31158390
[TBL] [Abstract][Full Text] [Related]
19. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
20. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
